Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. It operates through the following segments: Pharmaceuticals Manufacturing and Services, Financial Services, and Healthcare Insights and Analytics. The Pharmaceuticals Manufacturing and Services segment operates through the following divisions: Pharma Solutions, Critical Care, Consumer Products Services and Imaging. The Financial Services segment offers a complete suite of financial products to meet the diverse needs of its customers. The Healthcare Insights and Analytics segment provides indispensable insights to life sciences companies as well as healthcare providers and payers through a variety of high value-added data and analytics, research reports, and knowledge-based services. The company was founded on April 26, 1947 and is headquartered in Mumbai, India.
PIRAMAL ENTERPRISES LTD financial statements, including revenue, expenses, and profit: The total revenue of PEL for the last quarter is 23.02 B INR, and it's 198.13% higher compared to the previous quarter. The net income of Q1 25 is 2.76 B INR.
PIRAMAL ENTERPRISES LTD dividends overview: PEL dividends are paid annually. The last dividend per share was 11.00 INR. As of today, Dividend Yield (TTM)% is 0.97%.
PIRAMAL ENTERPRISES LTD earnings per share and revenue: PEL earnings per share for the last quarter are 12.26 INR whereas the estimation was -9.20 INR which accounts for 233.26% surprise. Company revenue for the same period amounts to 12.37 B INR despite the estimated figure of 11.50 B INR. Also watch annual changes over time to get a bigger picture of PEL earnings per share and revenue dynamics.
PIRAMAL ENTERPRISES LTD revenue breakdown overview: PIRAMAL ENTERPRISES LTD revenue for the last year amounted to 106.12 B INR, the most of which — 106.12 B INR — came from its highest performing source at the moment, Lending and Investing, the year earlier bringing 101.78 B INR. The greatest contribution to the revenue figure was made by India — last year it brought PIRAMAL ENTERPRISES LTD 106.12 B INR, and the year before that — 101.78 B INR.
Potential 50% Upside with Entry Price 1100 Target Price 1650, Timeframe 6-12 Months
Comments
Post a Comment